Roche Files Application In Europe For Tamiflu 30 And 45 Mg Capsules

... Roche has filed an application with regulatory authorities in Europe requesting an extension of the current Tamiflu license to include smaller capsules of 30 mg and 45 mg in addition to the 75 mg capsule already registered. These lower dosage strengths have been developed mainly for use in children for seasonal and pandemic influenza, as an alternative to the suspension formulation. [click link for full article] ...